九安醫療(002432.SZ):未來公司會依據市場需求,將中國具有競爭力的技術和產品推向美國市場
格隆匯2月23日丨九安醫療(002432.SZ)於2023年2月21日16:00-17:30接受機構調研時表示,具體財務數據要以公司2022年年度報吿為準,公司預約於2023年4月29日披露年報。公司通過試劑盒業務獲得了良好的資金儲備,為未來可以陸續推出更多爆款產品奠定了基礎。隨着iHealth額温計、試劑盒在美國暢銷,給iHealth品牌帶來了良好的品牌知名度和用户口碑,未來公司會依據市場需求,將中國具有競爭力的技術和產品推向美國市場。公司集中精力和資源,加速推動“糖尿病診療照護‘O+O’(Offline+Online)新模式在中國、美國的推廣”和“爆款產品”兩大核心戰略的實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.